COMPARISON OF IMMUNOHISTOCHEMISTRY, FISH, RTPCR METHODOLOGIES FOR DETECTION OF EML4-ALK FUSION GENE IN ADVANCED NON-SMALL CELL LUNG CARCINOMA

被引：0
作者：
Han, Xiao-hong [1 ,2 ]
Ma, Li [3 ]
Liu, Yutao [3 ]
Zhang, Ningning [3 ]
Li, Dan [3 ]
Shi, Yuankai [3 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp Inst, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Canc Inst, Med Oncol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
NSCLC; Immunohistochemistry; Fluorescent in situ hybridization; RT-PCR; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-024
引用
收藏
页码：S453 / S454
页数：2
相关论文
共 50 条
  • [21] The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4-ALK Rearranged Non-small Cell Lung Cancer
    Lin, Yen-Ting
    Liu, Yi-Nan
    Shih, Jin-Yuan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [22] Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK
    Katayama, Ryohei
    Khan, Tahsin M.
    Benes, Cyril
    Lifshits, Eugene
    Ebi, Hiromichi
    Rivera, Victor M.
    Shakespeare, William C.
    Iafrate, A. John
    Engelman, Jeffrey A.
    Shaw, Alice T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (18) : 7535 - 7540
  • [23] Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant
    To, Ka-Fai
    Tong, Joanna H. M.
    Yeung, King S. F.
    Lung, Raymond W. M.
    Law, Peggy P. Y.
    Chau, Shuk Ling
    Kang, Wei
    Tong, Carol Y. K.
    Chow, Chit
    Chan, Anthony W. H.
    Leung, Linda K. S.
    Mok, Tony S. K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 883 - 891
  • [24] Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non-Small-Cell Lung Cancer A Long-Term Comparison of ALK Detection in China
    Peng, Rongxue
    Zhang, Rui
    Zhang, Jiawei
    Tan, Ping
    Han, Yanxi
    Zhang, Kuo
    Lin, Guigao
    Xie, Jiehong
    Li, Jinming
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (07) : 876 - 884
  • [25] Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer
    Li, Ying
    Li, Yongwen
    Yang, Tong
    Wei, Sen
    Wang, Jing
    Wang, Min
    Wang, Yuli
    Zhou, Qinghua
    Liu, Hongyu
    Chen, Jun
    PLOS ONE, 2013, 8 (01):
  • [26] RET rearrangement as a mechanism of resistance to ALK-TKI in non-small cell lung cancer patient with EML4-ALK fusion: A case report
    Yan, Huan
    Zeng, Liang
    Zhang, Yongchang
    HELIYON, 2024, 10 (09)
  • [27] Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China
    Li, Yulong
    Zhang, Rui
    Peng, Rongxue
    Ding, Jiansheng
    Han, Yanxi
    Wang, Guojing
    Zhang, Kuo
    Lin, Guigao
    Li, Jinming
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) : 924 - 929
  • [28] Detection of EML4-ALK Fusion Gene in Chinese Non-Small Cell Lung Cancer by Using a Sensitive Quantitative Real-Time Reverse Transcriptase PCR Technique
    Fu, Sha
    Wang, Fang
    Shao, Qiong
    Zhang, Xu
    Duan, Li-Ping
    Zhang, Xiao
    Zhang, Li
    Shao, Jian-Yong
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (04) : 245 - 254
  • [29] Preliminary Orthogonal Analysis of EML4-ALK Gene Fusion Detection Methods in Chilean Patients with Lung Adenocarcinoma
    Freire, M.
    Lizana, R.
    Ramos, L.
    Sepulveda-Hermosilla, G.
    Blanco, A.
    Perez, P.
    Aren, O.
    Chernilo, S.
    Fernandez, C.
    Armisen, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S163 - S164
  • [30] EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries
    Elshatlawy, Mariam
    Sampson, Josephina
    Clarke, Katy
    Bayliss, Richard
    MOLECULAR ONCOLOGY, 2023, 17 (06) : 950 - 963
12345